Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Mark McCarty

ARTICLES

Congressional Democrats taking aim squarely at pre-emption

Orszag: patient behavior key to making healthcare affordable

Washington roundup: FTC and Virginia put brakes on Inova/Prince William merger

Competitiveness rationale for universal coverage resurfaces

Small business committee seeks more than SGR patch

Washington roundup: Medicare's LTCH payment hike targets trust fund 'solvency'

Innovation a money-maker but too often not well fleshed out

DES post-approval no longer just an after-thought for FDA

Market, technology, regulatory updates: The reimbursement triage: contract ... evidence ... cost

DES post-approval no longer just an FDA after-thought

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal